Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Isakson

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Biochemical Journal|July 21, 2001
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsM C Walker, R G Kurumbail, J R Kiefer, et al.
Arthritis and Rheumatism|September 29, 1998
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsL S Simon, F L Lanza, P E Lipsky, et al.
Lancet (London, England)|December 28, 1999
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparisonP Emery, H Zeidler, T K Kvien, et al.
Gastroenterology|December 12, 1997
A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cellsG G Sheng, J Shao, H Sheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Pharmacological analysis of cyclooxygenase-1 in inflammationC J Smith, Y Zhang, C M Koboldt, et al.
Blood|June 1, 1990
Further studies on growth factor production by the TC-1 stromal cell line: pre-B stimulating activityT A Woodward, I K McNiece, P L Witte, et al.
Journal of Medicinal Chemistry|May 23, 1997
1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2I K Khanna, R M Weier, Y Yu, et al.
Mayo Clinic Proceedings|November 24, 1999
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trialW G Bensen, J J Fiechtner, J I McMillen, et al.
Journal of Medicinal Chemistry|October 27, 1995
1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agentsJ J Li, G D Anderson, E G Burton, et al.
JAMA|December 2, 1999
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trialL S Simon, A L Weaver, D Y Graham, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Biochemical Journal|July 21, 2001
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsM C Walker, R G Kurumbail, J R Kiefer, et al.
Arthritis and Rheumatism|September 29, 1998
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsL S Simon, F L Lanza, P E Lipsky, et al.
Lancet (London, England)|December 28, 1999
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparisonP Emery, H Zeidler, T K Kvien, et al.
Gastroenterology|December 12, 1997
A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cellsG G Sheng, J Shao, H Sheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Pharmacological analysis of cyclooxygenase-1 in inflammationC J Smith, Y Zhang, C M Koboldt, et al.
Blood|June 1, 1990
Further studies on growth factor production by the TC-1 stromal cell line: pre-B stimulating activityT A Woodward, I K McNiece, P L Witte, et al.
Journal of Medicinal Chemistry|May 23, 1997
1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2I K Khanna, R M Weier, Y Yu, et al.
Mayo Clinic Proceedings|November 24, 1999
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trialW G Bensen, J J Fiechtner, J I McMillen, et al.
Journal of Medicinal Chemistry|October 27, 1995
1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agentsJ J Li, G D Anderson, E G Burton, et al.
JAMA|December 2, 1999
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trialL S Simon, A L Weaver, D Y Graham, et al.
Pageof 10